Zentalis Pharmaceuticals (ZNTL) Enterprise Value (2019 - 2026)
Zentalis Pharmaceuticals' quarterly Enterprise Value came in at -$211.8 million in Q1 2026, up 33.89% year-on-year from -$158.2 million in Q1 2025, and up 13.88% quarter-over-quarter from -$245.9 million in Q4 2025.
Zentalis Pharmaceuticals has reported Enterprise Value for 8 years, with the latest figure at -$211.8 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 33.89% year-over-year to -$211.8 million; the trailing twelve-month figure through Mar 2026 stood at -$211.8 million (up 33.89% YoY), and the FY2025 full-year result was -$245.9 million, up 30.13% from the prior year.
- Enterprise Value for Q1 2026 stood at -$211.8 million, up from -$245.9 million in the prior quarter.
- The five-year high for Enterprise Value was -$30.4 million in Q1 2022, with the low at -$482.8 million in Q4 2023.
- Average Enterprise Value over 5 years is -$155.3 million, with a median of -$54.8 million recorded in 2022.
- Year-over-year, Enterprise Value soared 88.89% in 2022 and sank 1026.8% in 2023.
- Tracing ZNTL's Enterprise Value over 5 years: stood at -$42.8 million in 2022, then slumped by 1026.8% to -$482.8 million in 2023, then rose by 27.11% to -$351.9 million in 2024, then jumped by 30.13% to -$245.9 million in 2025, then increased by 13.88% to -$211.8 million in 2026.
- The last three Enterprise Value figures came in at -$211.8 million (Q1 2026), -$245.9 million (Q4 2025), and -$41.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Zentalis Pharmaceuticals | 280.35 Mn | 280.35 Mn | - | -211.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -211.76 Mn |
| Dec 31, 2025 | -245.89 Mn |
| Sep 30, 2025 | -41.48 Mn |
| Jun 30, 2025 | -286.64 Mn |
| Mar 31, 2025 | -320.30 Mn |
| Dec 31, 2024 | -351.91 Mn |
| Sep 30, 2024 | -41.32 Mn |
| Jun 30, 2024 | -36.98 Mn |
| Mar 31, 2024 | -37.62 Mn |
| Dec 31, 2023 | -482.81 Mn |
| Sep 30, 2023 | -110.62 Mn |
| Jun 30, 2023 | -266.42 Mn |
| Mar 31, 2023 | -36.10 Mn |
| Dec 31, 2022 | -42.85 Mn |
| Sep 30, 2022 | -42.32 Mn |
| Jun 30, 2022 | -54.81 Mn |
| Mar 31, 2022 | -30.45 Mn |
| Dec 31, 2021 | -59.43 Mn |
| Sep 30, 2021 | -40.49 Mn |
| Jun 30, 2021 | -25.65 Mn |
| Mar 31, 2021 | -274.13 Mn |
| Dec 31, 2020 | -30.16 Mn |
| Sep 30, 2020 | -67.77 Mn |
| Jun 30, 2020 | -71.32 Mn |
| Mar 31, 2020 | -56.94 Mn |
| Dec 31, 2019 | -60.43 Mn |
| Sep 30, 2019 | -80.53 Mn |
| Jun 30, 2019 | -8.74 Mn |
| Mar 31, 2019 | -16.11 Mn |